Composite active range of motion (CX


Journal

Clinical rehabilitation
ISSN: 1477-0873
Titre abrégé: Clin Rehabil
Pays: England
ID NLM: 8802181

Informations de publication

Date de publication:
Jun 2020
Historique:
pubmed: 28 4 2020
medline: 13 11 2020
entrez: 28 4 2020
Statut: ppublish

Résumé

The aim of this study is to evaluate a novel composite measure of active range of motion (X Post hoc analysis of two randomized, placebo-controlled, double-blind studies with open-label extensions exploring changes in active function with abobotulinumtoxinA. Tertiary rehabilitation centers in Australia, Europe, and the United States. Adults with upper ( AbobotulinumtoxinA (⩽5 treatment cycles) in the upper or lower limb. X CX CX

Identifiants

pubmed: 32336148
doi: 10.1177/0269215520911970
pmc: PMC7263039
doi:

Substances chimiques

Acetylcholine Release Inhibitors 0
Botulinum Toxins, Type A EC 3.4.24.69
abobotulinumtoxinA EC 3.4.24.69

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

803-811

Références

Clin Rehabil. 2006 Feb;20(2):173-82
pubmed: 16541938
Lancet Neurol. 2015 Oct;14(10):992-1001
pubmed: 26318836
Stroke. 2000 Oct;31(10):2402-6
pubmed: 11022071
J Neurol Neurosurg Psychiatry. 2004 Nov;75(11):1547-51
pubmed: 15489384
PM R. 2018 Jul;10(7):693-703
pubmed: 29330071
Arch Phys Med Rehabil. 2012 Jun;93(6):1046-51
pubmed: 22440486
Eur J Phys Rehabil Med. 2010 Sep;46(3):411-21
pubmed: 20927007
J Neurol Neurosurg Psychiatry. 1983 Jun;46(6):521-4
pubmed: 6875585
Gait Posture. 2017 May;54:183-187
pubmed: 28324754
J Phys Ther Sci. 2015 Dec;27(12):3717-21
pubmed: 26834338
Neurology. 2017 Nov 28;89(22):2245-2253
pubmed: 29093068
Clin Neurophysiol. 2013 Mar;124(3):528-35
pubmed: 23063291
Ann Neurol. 1990 Oct;28(4):512-5
pubmed: 2252363
Zhonghua Er Ke Za Zhi. 2006 Dec;44(12):913-7
pubmed: 17254459
Phys Ther. 1975 Apr;55(4):355-9
pubmed: 1118465
Disabil Rehabil. 2017 Jul;39(14):1428-1434
pubmed: 27385274
Stroke. 2007 Nov;38(11):2953-9
pubmed: 17901383
Acta Neurol Belg. 2014 Jun;114(2):125-9
pubmed: 24515912
Muscle Nerve. 2005 May;31(5):552-71
pubmed: 15714511
Brain Inj. 2015;29(12):1452-9
pubmed: 26305105
PM R. 2018 Jan;10(1):1-10
pubmed: 28634000
Neurorehabil Neural Repair. 2001;15(1):23-30
pubmed: 11527276
Muscle Nerve. 2018 Feb;57(2):245-254
pubmed: 28590525
Ann Phys Rehabil Med. 2015 Jun;58(3):173-8
pubmed: 26027752
Arch Phys Med Rehabil. 2014 Nov;95(11):2013-20
pubmed: 24953249
Disabil Rehabil. 2008;30(1):44-53
pubmed: 17852258
J Neurol Neurosurg Psychiatry. 2010 Jan;81(1):46-52
pubmed: 19770162

Auteurs

Nicolas Bayle (N)

EA 7377 BIOTN, Service de Rééducation Neurolocomotrice, Université Paris-Est Créteil, Hospital Albert Chenevier-Henri Mondor, Créteil, France.

Pascal Maisonobe (P)

Biometry, Ipsen Pharma, Boulogne-Billancourt, France.

Romain Raymond (R)

Biostatistics, Ividata, Levallois-Perret, France.

Jovita Balcaitiene (J)

Global Medical Affairs, Ipsen Pharma, Boulogne-Billancourt, France.

Jean-Michel Gracies (JM)

EA 7377 BIOTN, Service de Rééducation Neurolocomotrice, Université Paris-Est Créteil, Hospital Albert Chenevier-Henri Mondor, Créteil, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH